Transcorneal or paracorneal penetration route for topical application of drugs to the eye. Mycophenolate mofetil as model substance;Transkornealer-parakornealer penetrationsweg für lokal applizierte pharmaka am auge: Mycophenolat mofetil als modellsubstanz

Ophthalmologe

Volumn 100, Issue 9, 2003, Pages 696-701

  Bertelmann, E ^a   Knapp, S ^a   Rieck, P ^a   Keipert, S ^a   Hartmann, C ^a   Pleyer, U ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Cyclodextrins; Esterases; Mycophenolate mofetil; Mycophenolic acid; Paracorneal penetration route; Topical immunosuppression

Indexed keywords

MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AQUEOUS HUMOR; CILIARY BODY; CONCENTRATION RESPONSE; CONJUNCTIVA; CONTROLLED STUDY; CORNEA; DOSE TIME EFFECT RELATION; DRUG FORMULATION; DRUG METABOLISM; DRUG PENETRATION; DRUG TISSUE LEVEL; IMMUNOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; IRIS; NONHUMAN; PARACORNEAL PENETRATION; RABBIT; REVIEW; SUSPENSION; TRANSCORNEAL PENETRATION;

ADMINISTRATION, TOPICAL; ANIMALS; CORNEA; CYCLODEXTRINS; EYE; IMMUNOSUPPRESSIVE AGENTS; MYCOPHENOLIC ACID; PRODRUGS; RATS; TISSUE DISTRIBUTION;

EID: 0141459625     PISSN: 0941293X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00347-003-0898-8     Document Type: Review

References (14)

1. Allison AC, Almquist SJ, Muller CD et al.(1991) In vitro immunosuppressive effects of mycophenolic acid and an ester prodrug, RS-61443. Transplant Proc 23 [Suppl 2]:10-14
2. Ahmed I, Patton TF (1985) Importance ofthe noncorneal absorption route in topical ophthalmic drug delivery. Invest Ophthalmol Vis Sci 26:584-587
3. Babiole M, Wilhelm F, Schoch C (2001) In vitro corneal permeation of unoprostone isopropyl (UI) and its metabolism in the isolated pig eye. J Ocul Pharmacol Ther 17:159-172
4. Chien DS, Homsy JJ, Gluchowski C, Tang-Liu DD (1990) Corneal and conjunctival/scleral penetration of p-aminocloro AGN 190342, and clonidine in rabbit eyes. Curr Eye Res 9:1051-1059
5. Coupland SE, Penfold PL, Billson FA (1994) Hydrolases of anterior segment tissues in the normal human, pig and rat eye: a comparative study. Graefes Arch Clin Exp Ophthalmol 232:182-191
6. Doane MG, Jensen AD, Dohlman CH (1978) Penetration routes of topically applied eye medications. Am J Ophthalmol 85:383-386.
7. Fulton B, Markham A (1996) Mycophenolate Mofetil: a review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in renal transplantation. Drugs 51:278-298
8. Lee VHL, Limoto DS, Takemoto KA (1983) Subcellular distribution of esterases in the bovine eye. Curr Eye Res 2:869-876
9. Lee VHL, Chang SC, Oshiro CM, Smith RE (1985) Ocular esterase composition in albino and pigmented rabbits: possible implications in ocular prodrug design and evaluation. Curr Eye Res 4:1117-1125
10. Reis A, Reinhard T, Voiculescu A, et al.(1999) Mycophenolate Mofetil versus Cyclosporine A in high-risk keratoplasty patients: a prospective, randomised clinical trial. Br J Ophthalmol 83:1268-1271
11. Schoenwald RD, Ward R (1978) Relationship between steroid permeability across excited rabbit cornea and octanol-water partition coefficients. J Pharm Sci 67:786-788
12. Schoenwald RD, Deshpande GS, Rethwisch DG, Barfknecht CF (1997) Penetration into the anterior chamber via the conjunctival/scleral pathway. J Ocul Pharmacol Ther 13:41-59
13. Siefert B, Pleyer U, Müller M et al.(1999) Influence of cyclodextrins on the In vitro corneal permeability and in vivo ocular distribution of thalidomide. J Ocular Parmacol Ther 15:429-438
14. Zierhut M, Stübinger N, Aboalchamat W et al.(2001) Immunsuppressive Therapie mit Mycophenolat Mofetil (CellCept®) in der Behandlung der Uveitis. Opthalmologe 98:647-651